Welcome to our dedicated page for CIBUS SEC filings (Ticker: CBUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cibus, Inc. (Nasdaq: CBUS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information on Cibus’ operations as an agricultural technology company that develops and licenses gene-edited plant traits to seed companies.
Through its recent Forms 8-K, Cibus has reported a range of material events, such as quarterly financial results and business updates, workforce reduction decisions, and the appointment of key executives and directors. For example, filings describe the appointment of a Chief Financial Officer under an executive employment agreement, the election of new board members with experience in technology, agriculture and finance, and actions to streamline the business by consolidating facilities and reducing headcount.
These filings also confirm that Cibus’ Class A common stock, with par value $0.0001 per share, is registered under Section 12(b) of the Exchange Act and trades on The Nasdaq Stock Market LLC under the symbol CBUS. Investors reviewing the filings can see how the company describes its focus on productivity traits for major row crops, its reliance on licensing and royalty arrangements, and its assessment of risks and strategic alternatives as referenced in its periodic reports.
On Stock Titan, Cibus filings are supplemented with AI-powered summaries that help explain the key points of lengthy documents, such as current reports on Form 8-K or sections of annual and quarterly reports. Users can quickly identify items related to executive changes, cost structure adjustments, or updates to trait development programs, and then drill down into the full text for more detail. Real-time updates from EDGAR, combined with AI-generated highlights, make it easier to track CBUS regulatory disclosures, including insider-related items reported on Form 4 and the narrative and risk discussions contained in Forms 10-K and 10-Q.
Cibus, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on June 2, 2026 at 10:00 a.m. Pacific Time. The agenda includes electing nine directors for one-year terms, approving on an advisory basis the compensation of named executive officers, and ratifying BDO USA, P.C. as independent auditor for the year ending December 31, 2026.
Holders of Class A Common Stock as of April 6, 2026, when 76,345,736 shares were outstanding, are entitled to one vote per share. The board is currently ten members but expects to reduce to nine after director Keith Walker steps down. Seven of nine post‑meeting directors are expected to be independent under Nasdaq rules, and the roles of Chairman and Interim Chief Executive Officer are separated.
The proxy describes detailed voting procedures for stockholders of record and beneficial owners, quorum requirements, the treatment of abstentions and broker non‑votes, and deadlines for submitting stockholder proposals or director nominations for the 2027 annual meeting. It also outlines the board’s committee structure, governance policies, insider trading and hedging restrictions, and a clawback policy for incentive-based compensation.
Cibus, Inc. director Urban Thomas filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows he held 0 shares of Class A Common Stock directly at the time of the report and does not list any recent purchases, sales, or option exercises.
Cibus, Inc. reported that its Board of Directors appointed Thomas Urban as a director, effective April 7, 2026. Urban is the founder of Agribusiness Advisors and has held leadership roles at CellFor, ArborGen, and Pioneer Hi-Bred International, and began his career at Goldman Sachs.
He will enter into the company’s standard indemnification agreement for directors and, under the Non-Employee Director Compensation Policy, will receive a $60,000 annual cash retainer and equity awards with a grant date value of $90,000, both prorated through the next annual shareholder meeting.
Cibus, Inc. senior vice president of research Noel Sauer reported a routine tax-withholding disposition of 1,763 shares of Class A Common Stock on March 30, 2026. The shares were valued at a weighted average price of $1.84 per share. After this transaction, Sauer directly owns 101,879 shares of Cibus stock.
Cibus, Inc. chief legal officer Jason Stokes reported a routine tax-related share disposition. On March 30, 2026, 3,695 shares of Class A Common Stock were withheld at a weighted average price of $1.83 per share to cover tax obligations. The withheld shares came from multiple trades priced between $1.81 and $1.88. After this transaction, Stokes directly held 110,865 shares of Cibus common stock.
Cibus, Inc. CFO Broos Carlo reported a tax-related share disposition. On this Form 4, 3,676 shares of Class A Common Stock were disposed of at a weighted average price of $1.87 per share to satisfy tax obligations by delivering securities. After this transaction, Carlo directly holds 97,275 shares.
This was a tax-withholding disposition tied to equity compensation rather than an open-market trade, so it functions as an administrative event and does not reflect an active buy or sell decision on the open market.
Cibus, Inc. Chief Scientific Officer and EVP Gregory Francis William Gocal reported a routine tax-withholding disposition of 8,954 shares of Class A Common Stock. The shares were applied at a weighted average price of $1.82 per share. After this transaction, he directly holds 365,890 shares of Cibus common stock.
Cibus, Inc. director and interim CEO, president and COO Peter Beetham reported a tax-withholding disposition of 16,112 shares of Class A Common Stock on March 30, 2026. The weighted average price was $1.85 per share, with trades ranging from $1.81 to $2.10. Following this withholding to cover obligations, he directly holds 491,825 shares, indicating this was a routine compensation-related event rather than an open-market sale.
Cibus, Inc. entered an underwriting agreement with BTIG, LLC for an underwritten public offering of 6,976,744 shares of Class A common stock at $2.15 per share. The company expects net proceeds of about $13.5 million, or $16.0 million if the 1,046,511-share overallotment option is fully exercised.
The offering is expected to close on or about March 27, 2026, subject to customary conditions, under a previously effective Form S-3 shelf registration. The underwriter will receive a 7.0% discount on gross proceeds, and directors, officers and the company agreed to a 60-day lock-up on additional sales, with customary exceptions.